ADMA BIOLOGICS INC (ADMA)

US0008991046 - Common Stock

6.55  +0.11 (+1.71%)

After market: 6.62 +0.07 (+1.07%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
258.21M154.10M80.90M42.20M29.30M
Cost Of Goods
169.27M118.80M79.80M61.30M39.50M
Gross Profit
88.94M35.30M1.20M-19.10M-10.20M
Operating Expenses
67.31M74.60M59.50M45.80M31.20M
Research and Development
3.30M3.60M3.60M5.90M2.30M
Selling, General, and Administrative Expenses
63.29M70.30M55.20M39.20M28.10M
Operating Income
21.63M-39.30M-58.40M-64.90M-41.40M
Interest Income/Expense
-23.41M-19.20M-13.00M-11.70M-8.20M
Other Income/Expense
-287.00K-600.00K-300.00K-100.00K-200.00K
Non Recurring Items
-26.17M-6.70M0.001.00M-10.00M
Income Before Taxes
-28.24M-65.90M-71.60M-75.70M-48.30M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-28.24M-65.90M-71.60M-75.70M-48.30M
EBITDA
29.96M-32.19M-52.90M-60.96M-38.14M
 
Per Share Data
EPS Diluted Total Ops
-0.13-0.33-0.51-0.88-0.89
Non GAAP EPS
-0.13-0.31-0.52-0.86-0.94
 
Statistics
Gross Profit Margin
34.44%22.91%1.48%-45.26%-34.81%
Profit Margin
-10.94%-42.76%-88.50%-179.38%-164.85%
Operating Profit Margin
8.38%-25.50%-72.19%-153.79%-141.30%

All data in USD

Charts